Get the Stockscreener App
1.86
98.25%
0.9218
After Hours:
1.65
-0.21
-11.29%
Nexalin Technology Inc stock is traded at $1.86, with a volume of 195.05M.
It is up +98.25% in the last 24 hours and up +123.96% over the past month.
Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.
See More
Previous Close:
$0.9382
Open:
$1.83
24h Volume:
195.05M
Relative Volume:
50.14
Market Cap:
$32.40M
Revenue:
$128.60K
Net Income/Loss:
$-4.60M
P/E Ratio:
-2.9524
EPS:
-0.63
Net Cash Flow:
$-3.74M
1W Performance:
+111.41%
1M Performance:
+123.96%
6M Performance:
+14.81%
1Y Performance:
+173.53%
1-Day Range:
$1.46
$2.00
1-Week Range:
$0.87
$2.00
52-Week Range:
$0.591
$4.4899
Nexalin Technology Inc Stock (NXL) Company Profile
Name
Nexalin Technology Inc
Sector
Industry
Phone
(832) 260-0222
Address
1776 YORKTOWN, HOUSTON
Compare NXL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NXL
Nexalin Technology Inc
|
1.86 | 16.34M | 128.60K | -4.60M | -3.74M | -0.63 |
|
ABT
Abbott Laboratories
|
134.27 | 231.52B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
SYK
Stryker Corp
|
375.29 | 141.16B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
BSX
Boston Scientific Corp
|
96.79 | 142.10B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
MDT
Medtronic Plc
|
97.87 | 126.13B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
75.74 | 45.04B | 5.69B | 1.41B | 577.90M | 6.9828 |
Nexalin Technology Inc Stock (NXL) Latest News
Why Is Micro-Cap Stock Nexalin Technology Rallying On Wednesday? - Benzinga
Nexalin shares skyrocket after Alzheimer’s study shows strong cognitive gains - MSN
Nexalin Technology Inc. (NXL) Stock Price | Live Quotes & Charts | NSC - StocksToTrade
Is Nexalin’s Stock Set to Skyrocket? - StocksToTrade
Nexalin's Game-Changing Alzheimer's Breakthrough Ignites a Wild Pre-Market Rally – Is This the Next Big Biotech Winner? - RagingBull
Is Nexalin’s Device Driving Stock Surge? - timothysykes.com
Nexalin stock soars after Alzheimer’s treatment shows cognitive benefits By Investing.com - Investing.com Australia
Nexalin stock soars after Alzheimer’s treatment shows cognitive benefits - Investing.com
Nexalin Technology announces additional positive clinical results in Alzheimer's disease with Gen-2 Sync neurostimulation device - MarketScreener
Is Nexalin Technology Inc a good long term investmentTechnical Breakout Signals & Free High Profit Capital Plays - earlytimes.in
Nexalin Technology Announces Additional Positive Clinical - GlobeNewswire
Nexalin Technology Announces Additional Positive Clinical Results in Alzheimer’s Disease with Gen-2 SYNC Neurostimulation Device - Stock Titan
Nexalin Technology Inc Stock Analysis and ForecastTrendline Breakouts & The Best Picks Hiding in Plain Sight - earlytimes.in
Why Nexalin Technology Inc. stock is trending among retail tradersJuly 2025 Review & Comprehensive Market Scan Reports - newser.com
Top chart patterns to watch in Nexalin Technology Inc. Equity WarrantGDP Growth & Step-by-Step Trade Execution Guides - newser.com
How moving averages guide Nexalin Technology Inc. tradingInsider Buying & Expert Verified Stock Movement Alerts - newser.com
Using Bollinger Bands to evaluate Nexalin Technology Inc. Equity Warrant2025 Major Catalysts & Weekly High Return Opportunities - newser.com
Technical signs of recovery in Nexalin Technology Inc. Equity WarrantEarnings Overview Report & Stock Market Timing Techniques - newser.com
Pattern recognition hints at Nexalin Technology Inc. upsideWeekly Profit Analysis & Community Supported Trade Ideas - newser.com
Published on: 2025-10-05 05:31:30 - newser.com
What does recent volatility data suggest for Nexalin Technology Inc.Quarterly Risk Review & Low Drawdown Trading Strategies - newser.com
How to use Fibonacci retracement on Nexalin Technology Inc. Equity WarrantWeekly Trade Review & Real-Time Stock Movement Alerts - newser.com
How to interpret RSI for Nexalin Technology Inc. Equity Warrant stockGap Up & Low Risk High Win Rate Stock Picks - newser.com
Volume spikes in Nexalin Technology Inc. stock – what they meanEarnings Summary Report & AI Driven Stock Movement Reports - newser.com
Volatility clustering patterns for Nexalin Technology Inc. Equity WarrantIndex Update & Weekly High Momentum Picks - newser.com
Published on: 2025-09-29 09:11:45 - newser.com
Nexalin Technology Inc Stock (NXL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Nexalin Technology Inc Stock (NXL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Shelton Carolyn Hamby | Sr. VP - Quality, Regulatory |
Mar 12 '25 |
Buy |
2.20 |
6,000 |
13,200 |
30,000 |
| Owens David | Chief Medical Officer |
Feb 04 '25 |
Buy |
3.10 |
1,000 |
3,100 |
155,793 |
| Owens David | Chief Medical Officer |
Feb 04 '25 |
Buy |
2.98 |
1,000 |
2,980 |
154,793 |
| Owens David | Chief Medical Officer |
Jan 28 '25 |
Buy |
2.70 |
1,500 |
4,050 |
153,793 |
| Owens David | Chief Medical Officer |
Jan 13 '25 |
Buy |
2.50 |
2,000 |
5,000 |
151,293 |
| Owens David | Chief Medical Officer |
Jan 23 '25 |
Buy |
2.70 |
1,000 |
2,700 |
152,293 |
| Owens David | Chief Medical Officer |
Oct 28 '24 |
Buy |
2.19 |
500 |
1,095 |
148,293 |
0.65%
1.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):